stock.name

Mylan N.V.

MYL

Market Cap$8.59B
Close$

Compare Mylan N.V.

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Mylan N.V.Mylan N.V.0-2%-1
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9

Share Statistics

Market cap$8.59 Billion
Enterprise Value$20.18 Billion
Dividend Yield$0.0 (-%)
Earnings per Share$0.52
Beta-
Outstanding Shares541,546,000
Avg 30 Day Volume7,142,403

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-
PEG-
Price to Sales0.0
Price to Book Ratio0.0
Enterprise Value to Revenue1.75
Enterprise Value to EBIT21.9
Enterprise Value to Net Income75
Total Debt to Enterprise0.61
Debt to Equity0.98

Revenue Sources

No data

ESG Score

No data

About Mylan NV

35,000 employees
CEO: Heather M. Bresch

Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geog...